Targeting an Epigenetic Biomarker for Fragile X

Epigenetics is bringing a needed perspective to a important public health issue. Many people with Fragile X have autism, or symptoms of autism. The condition is associated with learning, physical, social and emotional, speech and language, and sensory problems. Applied Behavioral Analysis treatment (ABA) is a set of methods which can be used to target and modify problematic symptoms and behaviors. It is effective – but also an arduous task in treating the symptoms of autism. Wouldn’t it be great if there was an epigenetic drug treatment which could be used with ABA producing an enhanced, synergistic effect? Neuroscience experts call Fragile X syndrome a disease of synaptic plasticity. Neuropychologists have already determined that early intervention produces the most effective … Continue reading →